CXCL12 and pulmonary arterial hypertension: However, how the reduction of ACKR4 leads to the elevation of CXCL12 remains unclear and vice versa, which warrants further investigation in future studies to decipher a more comprehensive chemokine-related atlas in the setting of PAH.